openPR Logo
Press release

CD BioSciences Introduces Multicolor Immunofluorescence Staining Kits for Enhanced Research

04-25-2024 06:46 PM CET | Health & Medicine

Press release from: ABNewswire

CD BioSciences Introduces Multicolor Immunofluorescence

CD BioSciences launches new Multicolor Immunofluorescence Staining Kits for researchers.
CD BioSciences, a US-based biotechnology company focusing on the development of imaging technologies, is proud to announce the launch of its new Multicolor Immunofluorescence Staining Kits [https://www.bioimagingtech.com/multicolor-histological-staining-kits.html]. These kits empower researchers to achieve high-quality staining of tissues and cells utilizing 2-7 different colors, enabling more detailed and comprehensive analysis.

By providing researchers with the tools they need to achieve exceptional multicolor staining, CD BioSciences is committed to supporting groundbreaking discoveries across various fields of biological research. These new Multicolor Immunofluorescence Staining Kits are specifically designed for high-quality staining of human and small mammalian tissue sections and cells. With CD BioSciences' advanced staining solutions, scientists can enhance their research by obtaining accurate and reliable results and unlock deeper insights into their samples.

Utilizing advanced technologies like Tyrosine Signal Amplification (TSA), these kits provide superior signal amplification and exceptional staining quality, particularly for human and small mammal samples. TSA utilizes HRP-conjugated secondary antibodies to catalyze the stable covalent binding of fluorescein substrate to antigen and amplify the fluorescent signal. In addition, the double immunofluorescence (IF) procedure is designed to detect the co-distribution of two different antigens in the same sample.

With these advancements, CD BioSciences' Multicolor Immunofluorescence Staining Kits offer researchers a versatile and powerful solution for a wide range of applications. For example, the 7-Color mIF Staining Kit for Mouse Tissue, TSA (Catalog No. MCIS001) can be used for immunofluorescence staining of tissues, paraffin sections and TMA. This 7-color mIF Staining Kit utilizes TSA technology to efficiently detect 7 different antigens on mouse tissue or cell samples when paired with user-supplied rabbit primary antibodies. Multiple labeling can be achieved by using a heat repair method to remove non-covalently bound antibodies and performing a second round of incubation with the next primary antibody and another fluorogenic substrate.

2-Color IF Staining Kit for Mouse (Green) and Rabbit (Red) antibody (Catalog No. MCIS013) can be applied in IHC, ICC/IF, Flow, paraffin and frozen sections. The tissue microenvironment contains complex cellular components, and researchers can detect and identify different compositions through multiple immunofluorescence staining. This new 2-Color IF Staining Kit is paired with user-supplied mouse and rabbit primary antibodies to efficiently detect 2 different antigens on paraffin and frozen sections. The kit's IF procedure is designed to detect the co-distribution of two different antigens in the same sample. Dual immunofluorescence staining allows simultaneous detection of mouse and rabbit primary antibodies. Please note that all of these kits are for research use only.

CD BioSciences offers Multicolor Immunofluorescence Staining Kits to empower researchers to explore the intricate details of cellular and tissue structures with unprecedented accuracy and sensitivity. To learn more about the new kits, please visit https://www.bioimagingtech.com/multicolor-immunofluorescence-staining-kits.html [https://www.bioimagingtech.com/multicolor-histological-staining-kits.html].

About CD BioSciences

CD BioSciences is a biotechnology company committed to the development of imaging technology for many years. Its scientists can utilize high-content imaging, nanoparticle imaging, imaging flow cytometry, time-lapse imaging, and other techniques to image cell structure, cell migration, cell proliferation, pathogen infection mechanisms, and interactions between protein molecules.

Media Contact
Company Name: CD BioSciences
Contact Person: Michelle Moser
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=cd-biosciences-introduces-multicolor-immunofluorescence-staining-kits-for-enhanced-research]
State: New York
Country: United States
Website: https://www.bioimagingtech.com/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release CD BioSciences Introduces Multicolor Immunofluorescence Staining Kits for Enhanced Research here

News-ID: 3476804 • Views:

More Releases from ABNewswire

Next-generation Firewall Market Demand, Latest Trends, Outlook, Size, Share, Applications, Advance Technology And Forecast To 2028
Next-generation Firewall Market Demand, Latest Trends, Outlook, Size, Share, App …
Next-generation Firewall Market by Offering (Hardware, Software, Services), Deployment Mode (On-premises, Cloud/Virtual), Organization Size (Large Enterprises, SMEs), Vertical (BFSI, Government, Other Verticals) and Region - Global Forecast to 2028 The size of the global Next-generation Firewall Market [https://www.marketsandmarkets.com/Market-Reports/next-generation-firewall-ngfw-market-32240698.html?utm_campaign=nextgenerationfirewallngfwmarket&utm_source=abnewswire.com&utm_medium=paidpr] is expected to increase at a Compound Annual Growth Rate (CAGR) of 11.4% from USD 5.0 billion in 2023 to USD 8.6 billion by 2028. Next-Generation Firewalls (NGFWs) are essential for complying with
Logistics & Healthcare Use Cases Drive Embodied AI Market to USD 23.06 Billion by 2030, at 39.0% CAGR
Logistics & Healthcare Use Cases Drive Embodied AI Market to USD 23.06 Billion b …
The global Embodied AI Market in terms of revenue is estimated to be worth $4.44 billion in 2025 and is poised to reach $23.06 billion by 2030, growing at a CAGR of 39.0% during the forecast period. The report "Embodied AI Market [https://www.marketsandmarkets.com/Market-Reports/embodied-ai-market-83867232.html?utm_source=abnewswire.com&utm_medium=PaidPR&utm_campaign=embodiedaimarket] by Product Type [Robots (Humanoid Robots, Mobile Robots, Industrial Robots, Service Robots, Cobots), Exoskeletons, Autonomous Systems, Smart Appliances], Level of Embodiment (Level 1, Level 2, Level 3) -
Global Postbiotics Market Set to Reach USD 224.8 Million by 2030, Growing at 8.9% CAGR
Global Postbiotics Market Set to Reach USD 224.8 Million by 2030, Growing at 8.9 …
Postbiotics Market by Source (Bacteria, Yeast), Application (Functional Food & Beverages, Dietary Supplements, Animal Feed, Cosmetics & Personal Care, and Pharmaceuticals), Form, Function, Manufacturing Technology, and Region - Global Forecast to 2030 The postbiotics market [https://www.marketsandmarkets.com/Market-Reports/postbiotics-market-237110254.html] is valued at USD 146.7 million in 2025 and is projected to reach USD 224.8 million by 2030, growing at a CAGR of 8.9%. Growth is being fueled by rising consumer awareness of the link
Acrylic Resins Market Size, Competitor Ranking Analysis, Market Trend Forecast Report 2025-2030 | Top Key Players Analysis
Acrylic Resins Market Size, Competitor Ranking Analysis, Market Trend Forecast R …
The Acrylic Resins Market is growing steadily, driven by demand in coatings, construction, automotive, and electronics. Key players like BASF, Dow, Mitsubishi Chemical Group, Sumitomo Chemical, and Arkema are leading with innovative, durable, and eco-friendly resin solutions. Their global reach and strong R&D capabilities ensure sustainable advancements, meeting evolving industry needs across diverse end-use applications. The acrylic resins market is projected to reach USD 28.55 billion by 2030 from USD 21.89

All 5 Releases


More Releases for BioSciences

Nanostructured Drug Market Poised for Growth with Advancements in Targeted Deliv …
Nanostructured Drug Market Overview Nanostructured Drug Market is projected to grow significantly during the forecast period, driven by advancements in nanotechnology and increasing demand for targeted drug delivery systems. The latest report (2025-2032) on the Nanostructured Drug Market by Coherent Market Insights offers an in-depth analysis of market trends, growth factors, challenges, and competition. It explores market size, revenue, production, consumption, and CAGR, using reliable research methods for accuracy. The report also
CRISPR-Based Diagnostics Market for Infectious Diseases & Cancer Detection By 20 …
Global CRISPR-Based Diagnostics Market reached at a CAGR during the forecast period 2024-2031. Crispr-Based Diagnostics Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate
CRISPR-Based Diagnostics Market: Global Type, Trends, Service, Growth, Opportuni …
The CRISPR-Based Diagnostics Market study by DataM Intelligence offer an in-depth analysis of the market, presenting insightful observations, statistics, historical data, and industry-validated market insights. The report delves into the competitive positioning of key companies, examining factors such as product offerings, pricing strategies, financial health, product portfolios, growth initiatives, and geographical reach. Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: - https://datamintelligence.com/download-sample/crispr-based-diagnostics-market What is the projected
CRISPR Based Diagnostics Market Growing Rapidly by 2031 - Sherlock Biosciences, …
DataM Intelligence has published a new research report on "CRISPR Based Diagnostics Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status. Get a Free Sample Research PDF
Glycated Albumin Market to See Booming Growth 2024-2031 | Lifespan Biosciences, …
Glycated Albumin Market Trends Overview 2024-2031: A new Report by Coherent Market Insights, titled "Glycated Albumin Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031," offers a comprehensive analysis of the industry, which comprises insights on the Glycated Albumin market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. This report has a complete table of contents, figures, tables, and charts, as well as insightful
Congenital Adrenal Hyperplasia Market to Witness Growth by 2032, Estimates Delve …
DelveInsight's "Congenital Adrenal Hyperplasia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Congenital Adrenal Hyperplasia, historical and forecasted epidemiology as well as the Congenital Adrenal Hyperplasia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Congenital Adrenal Hyperplasia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here: https://www.delveinsight.com/sample-request/congenital-adrenal-hyperplasia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Some of